The protein name Grcc10 is not a standard nomenclature for a protein and does not correspond to commonly recognized protein or gene naming conventions. It is possible that Grcc10 could be a misprint, an internal identifier used by a specific research project, or a less common designation that has not been widely adopted in the scientific community.In standard scientific contexts, protein names often reflect their function (e.g., "hemoglobin"), their structural features (e.g., "triacylglycerol lipase"), or are found in the gene that encodes them (e.g., "BRCA1" protein from the BRCA1 gene). Gene names often include a combination of letters and numbers, and in model organisms like mice and rats, gene symbols are typically italicized and all uppercase (for mice) or all lowercase (for rats), such as "Trp53" for mice or "trp53" for rats.
If Grcc10 is supposed to refer to a gene or protein, it is necessary to have the correct naming convention to provide accurate information. For example, it might be a shorthand or an abbreviated code for a gene used in a specific laboratory or database, or possibly a part of a larger identifier.To obtain information about a gene or protein, the correct and full name or identifier is essential. If Grcc10 were a valid identifier, one would typically search for it in biological databases like the National Center for Biotechnology Information (NCBI), UniProt, or similar repositories that catalog genes and proteins. These databases provide comprehensive information, including the gene's location on the chromosome, its function, the structure of the protein it encodes, and its role in various biological processes and pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an adenylate cyclase activator, known to increase cyclic AMP (cAMP) levels in cells, potentially affecting GRCC10 activity through modulated signaling. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective phosphodiesterase inhibitor, increasing cAMP and cGMP levels, which could influence signaling pathways related to GRCC10. | ||||||
Bis(pinacolato)diboron | 73183-34-3 | sc-252467 sc-252467A | 1 g 5 g | $44.00 $82.00 | ||
PDGF binds to its receptor, triggering signaling pathways that may impact GRCC10 activity or expression. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates its receptor and downstream signaling pathways, which may intersect with GRCC10-related pathways. | ||||||
Thymosin β4 | 77591-33-4 | sc-396076 sc-396076A | 1 mg 100 mg | $134.00 $7140.00 | ||
TGF-beta activates SMAD and non-SMAD signaling pathways, possibly influencing GRCC10 activity. | ||||||
SAG | 912545-86-9 | sc-212905 sc-212905A | 1 mg 5 mg | $166.00 $421.00 | 27 | |
SAG activates the Hedgehog signaling pathway, potentially influencing GRCC10 activity. | ||||||